Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Jan 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,771 n/a
Apr 3, 2009 vagelos p roy Director Disposition (Non Open Market) 14,976 n/a
Oct 5, 2009 vagelos p roy Director Disposition (Non Open Market) 10,796 n/a
Jun 23, 2009 vagelos p roy Director Disposition (Non Open Market) 50,384 n/a
Jul 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,837 n/a
Apr 12, 2010 vagelos p roy Director Disposition (Non Open Market) 7,952 n/a
Jun 18, 2010 vagelos p roy Director Disposition (Non Open Market) 31,761 n/a
Jul 2, 2010 vagelos p roy Director Disposition (Non Open Market) 9,021 n/a
Jul 7, 2010 vagelos p roy Director Disposition (Non Open Market) 125,000 n/a
Oct 4, 2010 vagelos p roy Director Disposition (Non Open Market) 8,035 n/a
Jan 4, 2011 vagelos p roy Director Disposition (Non Open Market) 6,311 n/a
Jan 12, 2011 vagelos p roy Officer Disposition (Non Open Market) 1,203 n/a
Apr 4, 2011 vagelos p roy Officer Disposition (Non Open Market) 4,954 n/a
Jan 8, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,254 n/a
Apr 4, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,215 n/a
Oct 2, 2013 vagelos p roy Officer Disposition (Non Open Market) 73,596 n/a
Oct 9, 2013 vagelos p roy Officer Disposition (Non Open Market) 679 n/a
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
May 6, 2013 van plew daniel p Officer Disposition (Non Open Market) 15,323 260.44
Apr 27, 2012 van plew daniel p Officer Disposition (Non Open Market) 15,990 138.36
Showing 401-420 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)